MREO CIK: 1719714

Mereo BioPharma Group plc

  • United Kingdom
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
−48.8
FY23:
−21.1
FY24:
−32.8
FY25:
−31.0
Change from FY22 to FY25
millions USD
FY22:
1.99
FY23:
−0.42
FY24:
−0.70
FY25:
−0.02
Change from FY22 to FY25
millions USD
FY22:
0.20
FY23:
7.97
FY24:
46.1
FY25:
0.33
millions USD
FY22:
–
FY23:
−10.8
FY24:
12.4
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−48.8
FY23:
−21.1
FY24:
−32.8
FY25:
−31.0

All amounts in millions USD Data source:SEC EDGAR